Author:
Walters Suzan M.,Baker Robin,Frank David,Fadanelli Monica,Rudolph Abby E.,Zule William,Fredericksen Rob J.,Bolinski Rebecca,Sibley Adams L.,Go Vivian F.,Ouellet Lawrence J.,Pho Mai T.,Seal David W.,Feinberg Judith,Smith Gordon,Young April M.,Stopka Thomas J.
Abstract
Abstract
Aim
Illicitly manufactured fentanyl and its analogs are the primary drivers of opioid overdose deaths in the United States (U.S.). People who use drugs may be exposed to fentanyl or its analogs intentionally or unintentionally. This study sought to identify strategies used by rural people who use drugs to reduce harms associated with unintentional fentanyl exposure.
Methods
This analysis focused on 349 semi-structured qualitative interviews across 10 states and 58 rural counties in the U.S conducted between 2018 and 2020. Interview guides were collaboratively standardized across sites and included questions about drug use history (including drugs currently used, frequency of use, mode of administration) and questions specific to fentanyl. Deductive coding was used to code all data, then inductive coding of overdose and fentanyl codes was conducted by an interdisciplinary writing team.
Results
Participants described being concerned that fentanyl had saturated the drug market, in both stimulant and opioid supplies. Participants utilized strategies including: (1) avoiding drugs that were perceived to contain fentanyl, (2) buying drugs from trusted sources, (3) using fentanyl test strips, 4) using small doses and non-injection routes, (5) using with other people, (6) tasting, smelling, and looking at drugs before use, and (7) carrying and using naloxone. Most people who used drugs used a combination of these strategies as there was an overwhelming fear of fatal overdose.
Conclusion
People who use drugs living in rural areas of the U.S. are aware that fentanyl is in their drug supply and use several strategies to prevent associated harms, including fatal overdose. Increasing access to harm reduction tools (e.g., fentanyl test strips, naloxone) and services (e.g., community drug checking, syringe services programs, overdose prevention centers) should be prioritized to address the polysubstance-involved overdose crisis. These efforts should target persons who use opioids and other drugs that may contain fentanyl.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference116 articles.
1. Gumas ED, Baumgartner JC. “U.S. Overdose Deaths Remain Higher Than in Other Countries — How Harm-Reduction Programs Could Help. To the Point (blog), Commonwealth Fund, June 22, 2023. https://doi.org/10.26099/0eb5-9d85
2. Hedegaard H, Miniño A, Spencer MR, Warner M. Drug overdose deaths in the United States, 1999–2020. NCHS data brief. 2022(428).
3. Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN. Trends in opioid toxicity-related deaths in the US before and after the start of the COVID-19 Pandemic, 2011–2021. JAMA Netw Open. 2023;6(7):e2322303.
4. Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022;457:1–8.
5. Centers for Disease Control and Prevention. National Vital Statistics System. Provisional Drug Overdose Death Counts. Accessed: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm